Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Neurotrope Inc. (NTRP)

1.06   -0.05 (-4.5%) 10-01 15:35
Open: 1.13 Pre. Close: 1.11
High: 1.14 Low: 1.03
Volume: 1,647,850 Market Cap: 25M
Neurotrope, Inc. is a biopharmaceutical company, which engages in the pre-clinical and clinical development of its product candidates. The company is headquartered in New York City, New York and currently employs 5 full-time employees. The firm is focused on developing a product platform based upon a drug candidate called bryostatin for the treatment of Alzheimer's disease (AD), which is in the clinical testing stage. Bryostatin, which is a protein kinase C (PKC) Alpha and e activator, is also developed for other neurodegenerative or cognitive diseases and dysfunctions, which are in pre-clinical testing. Its second generation PKC activators, such as the Bryologs are meant for the treatment of central nervous system disorders, lysosomal storage diseases, stroke, cardio protection and traumatic brain injury. The company develops Bryostatin-1 for the treatment of Alzheimer's disease along with the rare (Orphan) diseases, such as Fragile X Syndrome and Niemann-Pick Type C. It has completed Phase IIa clinical trials of Bryostatin-1 for the treatment of patients with AD.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 1.483 - 1.491 1.491 - 1.5
Low: 1.062 - 1.069 1.069 - 1.077
Close: 1.097 - 1.109 1.109 - 1.122

Technical analysis

as of: 2020-10-01 3:07:31 PM
Overall:       
Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 1.53     One year: 1.73
Support: Support1: 1.03    Support2: 0.86
Resistance: Resistance1: 1.31    Resistance2: 1.48
Pivot: 1.16
Moving Average: MA(5): 1.10     MA(20): 1.15
MA(100): 1.21     MA(250): 1.07
MACD: MACD(12,26): -0.01     Signal(9):
Stochastic oscillator: %K(14,3): 19.05     %D(3): 27.13
RSI: RSI(14): 36.34
52-week: High: 3.85  Low: 0.63  Change(%): 51.9
Average Vol(K): 3-Month: 46011  10-Days: 165060

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
NTRP has closed below the lower band by 0.6%. If price is in a downtrend band; this downward trend in price might continue. However a short term pullback inside the band is likely. Bollinger Bands are 12.9% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Thu, 01 Oct 2020
Notable News Spotlight: Neurotrope (NASDAQ:NTRP) – Pro Magzine - Pro Magzine

Thu, 01 Oct 2020
Neurotrope Inc. (NTRP) distance from 200-day Simple Moving Average is $1.1478: Right on the Precipice - News Daemon

Wed, 30 Sep 2020
Here is why Neurotrope Inc. (NTRP) recent weekly performance of -5.08% shouldn’t bother you at All - The InvestChronicle

Wed, 30 Sep 2020
What Is Going On With Neurotrope, Inc. (NASDAQ:NTRP)? - Stocks Register

Wed, 30 Sep 2020
Neurotrope, Inc. (NTRP) investors to reap big returns again - Marketing Sentinel

Wed, 30 Sep 2020
Hot Condition Now? Neurotrope, Inc. (NTRP) - Digital Market News

Financial Analysis

Growth n/a
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability n/a
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency n/a
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency n/a
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Underperform
Return on Equity: Neutral Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 24
Shares Float (M) 20
% Held by Insiders 17.87
% Held by Institutions 6.88
Shares Short (K) 94
Shares Short P. Month (K) 126

Stock Financials

EPS -0.717
EPS Est This Year -1.890
EPS Est Next Year -1.960
Book Value (p.s.) 1.260
Profit Margin
Operating Margin
Return on Assets (ttm) -28.9
Return on Equity (ttm) -46.7
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.) -0.514
Qtrly Earnings Growth
Operating Cash Flow (M) -8
Levered Free Cash Flow (M) -4

Stock Valuations

PE Ratio -1.48
PEG Ratio
Price to Book value 0.84
Price to Sales
Price to Cash Flow -3.19

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.